All Pharma News
Approval provided for Angelini’s cenobamate

Approval provided for Angelini’s cenobamate
PHARMATIMES
16 May 2023
Share Share
Italy`s Angelini invests up to $506 mln in Japan`s JCR for epilepsy drug

Italy`s Angelini invests up to $506 mln in Japan`s JCR for epilepsy drug
Gabrielle Masson REUTERS
12 May 2023
Share Share
SK Biopharmaceuticals` Partner Angelini Pharma Launches Cenobamate in France

SK Biopharmaceuticals` Partner Angelini Pharma Launches Cenobamate in France
PRNEWSWIRE
08 Dec 2022
Share Share
Cenobamate is Now Available in France and Belgium

Cenobamate is Now Available in France and Belgium
BUSINESSWIRE
07 Dec 2022
Share Share
Angelini Industries appoints Jacopo Andreose new CEO of Angelini Pharma

Angelini Industries appoints Jacopo Andreose new CEO of Angelini Pharma
PRESS RELEASE
22 Nov 2022
Share Share
Cenobamate for the Treatment of Drug-Resistant Focal-Onset Seizures in Adults

Cenobamate for the Treatment of Drug-Resistant Focal-Onset Seizures in Adults
BUSINESSWIRE
01 Apr 2022
Share Share
Angelini Pharma, a New Partner in Epilepsy

Angelini Pharma, a New Partner in Epilepsy
BUSINESSWIRE
25 Mar 2022
Share Share
Angelini Pharma, a new partner in Epilepsy

Angelini Pharma, a new partner in Epilepsy
BUSINESSWIRE
14 Feb 2022
Share Share
Angelini Pharma and Lumira launch the Angelini Lumira Biosciences Fund (ALBF)

Angelini Pharma and Lumira launch the Angelini Lumira Biosciences Fund (ALBF)
GLOBENEWSWIRE
28 Jul 2021
Share Share
Angelini Pharma and Lumira launch the Angelini Lumira Biosciences Fund (ALBF)

Angelini Pharma and Lumira launch the Angelini Lumira Biosciences Fund (ALBF)
GLOBENEWSWIRE
28 Jul 2021
Share Share